HBIO logo

Harvard Bioscience (HBIO) Company Overview

Profile

Full Name:

Harvard Bioscience, Inc.

Sector:

Healthcare

Country:

United States

IPO:

March 19, 2001

Indexes:

Not included

Description:

Harvard Bioscience (HBIO) is a company that develops and sells scientific tools and equipment for life science research. They provide innovative products for studying biology, including instruments for measuring and analyzing biological processes, helping researchers advance their work in medicine and biology.

Events Calendar

Earnings

Next earnings date:

Mar 7, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 7, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 4, 2013

Analyst ratings

Recent major analysts updates

Jun 22, 23 Benchmark
Speculative Buy
Apr 26, 23 Keybanc
Overweight
Apr 26, 23 Benchmark
Buy
Mar 10, 23 Benchmark
Buy
Nov 9, 22 Keybanc
Overweight
Aug 5, 22 Keybanc
Overweight
Nov 10, 20 Keybanc
Overweight
Feb 27, 20 Benchmark
Speculative Buy
Nov 17, 16 Singular Research
Buy
Jul 28, 15 Benchmark
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Harvard Bioscience?
  • Does Harvard Bioscience pay dividends?
  • What sector is Harvard Bioscience in?
  • What industry is Harvard Bioscience in?
  • What country is Harvard Bioscience based in?
  • When did Harvard Bioscience go public?
  • Is Harvard Bioscience in the S&P 500?
  • Is Harvard Bioscience in the NASDAQ 100?
  • Is Harvard Bioscience in the Dow Jones?
  • When was Harvard Bioscience's last earnings report?
  • When does Harvard Bioscience report earnings?
  • Should I buy Harvard Bioscience stock now?

What is the ticker symbol for Harvard Bioscience?

The ticker symbol for Harvard Bioscience is NASDAQ:HBIO

Does Harvard Bioscience pay dividends?

No, Harvard Bioscience does not pay dividends

What sector is Harvard Bioscience in?

Harvard Bioscience is in the Healthcare sector

What industry is Harvard Bioscience in?

Harvard Bioscience is in the Medical Instruments & Supplies industry

What country is Harvard Bioscience based in?

Harvard Bioscience is headquartered in United States

When did Harvard Bioscience go public?

Harvard Bioscience's initial public offering (IPO) was on March 19, 2001

Is Harvard Bioscience in the S&P 500?

No, Harvard Bioscience is not included in the S&P 500 index

Is Harvard Bioscience in the NASDAQ 100?

No, Harvard Bioscience is not included in the NASDAQ 100 index

Is Harvard Bioscience in the Dow Jones?

No, Harvard Bioscience is not included in the Dow Jones index

When was Harvard Bioscience's last earnings report?

Harvard Bioscience's most recent earnings report was on Nov 7, 2024

When does Harvard Bioscience report earnings?

The next expected earnings date for Harvard Bioscience is Mar 7, 2025

Should I buy Harvard Bioscience stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions